Tech Company Financing Transactions

Omicia Funding Round

ARTIS Ventures, Acadia Woods Ventures and Bay City Capital participated in a $6.8 million Series A funding round for Omicia. The round was announced by the company on 1/8/2014.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1625 Clay St. 2nd Floor
Oakland, CA 94612
USA

Phone

(510) 595-0800

Website

www.omicia.com

Email Address

[email protected]

Overview

Omicia is unlocking the potential of personalized medicine. Our mission is to help researchers and clinicians understand and apply the most relevant information from personal genome sequences, to improve disease management and medical outcomes.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Matt Tindall

        

Chief Medical Officer

Paul Billings

        

Chief Operating Officer

Adam Grant

        

Chief Scientific Officer

Martin Reese

        

Chief Technical Officer

Edward Kiruluta

        

VP - Product Management

Charlene Rigby

        

Browse more venture capital transactions:

Prev: 1/8/2014: Aplicor venture capital transaction
Next: 1/8/2014: Eden Park Illumination venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary